Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

Autor: Lentz, S.R. *, Ehrenforth, S., Abdul Karim, F., Matsushita, T., Weldingh, K.N., Windyga, J., Mahlangu, J.N.
Zdroj: In Journal of Thrombosis and Haemostasis August 2014 12(8):1244-1253
Databáze: ScienceDirect
Externí odkaz: